Cooper IS , Lee AS . Cryostatic congelation: a system for producing a limited, controlled region of cooling or freezing of biologic tissues. J Nerv Ment Dis 1961; 133: 259-63.

Sugiura N , Takara K , Ohto M , Okuda K , Hirroka N . Treatment of small hepatocellular carcinoma by percutaneous injection of ethanol into tumor with real—time ultrasound monitoring. Acta Hepatol Jpn 1983; 24: 920.

Rossi S , Fornari F , Buscarini L . Percutaneous ultrasound—guided radiofrequency electrocautery for the treatment of small hepatocellular carcinoma. J Interv Radiol 1993; 8: 97-103.

Seki T , Wakabayashi M , Nakagawa T , Itho T , Shiro T , Kunieda K , et al. Ultrasonically guided percutaneous microwave coagulation therapy for small hepatocellular carcinoma. Cancer 1994; 74(3): 817-25.

Yi CA , Lee HY , Kim TJ , Lee KS . Management of CT screening—detected persistent nonsolid pulmonary nodules: an Asian perspective. Radiology 2016; 280(1): 324-6.

Cornelis FH, Solomon SB. Treatment of primary liver tumors and liver metastases, part 2: non—nuclear medicine techniques. J Nucl Med 2018; 59(12): 1801-8.

Knavel EM , Brace CL . Tumor ablation: common modalities and general practices. Tech Vasc Interv Radiol 2013; 16(4): 192-200.

Ahmed M , Brace CL , Lee Jr FT , Goldberg SN . Principles of and advances in percutaneous ablation. Radiology 2011; 258(2): 351-69.

Livraghi T , Solbiati L , Meloni MF , Gazelle GS , Halpern EF , Goldberg SN . Treatment of focal liver tumors with percutaneous radio—frequency ablation: complications encountered in a multicenter study. Radiology 2003; 226(2): 441-51.

Gervais DA , McGovern FJ , Arellano RS , McDougal WS , Mueller PR . Renal cell carcinoma: clinical experience and technical success with radio—frequency ablation of 42 tumors. Radiology 2003; 226(2): 417-24.

Fan L , Lin Y , Fu Y , Wang J . Small cell lung cancer with liver metastases: from underlying mechanisms to treatment strategies. Cancer Metastasis Rev 2024; 44(1): 5.

Shimada K , Sakamoto Y , Esaki M , Kosuge T . Role of the width of the surgical margin in a hepatectomy for small hepatocellular carcinomas eligible for percutaneous local ablative therapy. Am J Surg 2008; 195(6): 775-81.

Gillams A , Cassoni A , Conway G , Lees W . Radiofrequency ablation of neuroendocrine liver metastases: the Middlesex experience. Abdom Imaging 2005; 30(4): 435-41.

Lencioni R , Cioni D , Crocetti L , Franchini C , Pina CD , Lera J , et al. Early—stage hepatocellular carcinoma in patients with cirrhosis: long—term results of percutaneous image—guided radiofrequency ablation. Radiology 2005; 234(3): 961—7.

Seror O. Ablative therapies: advantages and disadvantages of radiofrequency, cryotherapy, microwave and electroporation methods, or how to choose the right method for an individual patient? Diagn Interv Imaging 2015; 96(6): 617-24.

Karanicolas PJ , Jarnagin WR , Gonen M , Tuorto S , Allen PJ , DeMatteo RP , et al. Long—term outcomes following tumor ablation for treatment of bilateral colorectal liver metastases. JAMA Surg 2013; 148(7): 597-601.

Yi Y , Zhang Y , Wei Q , Zhao L , Han J , Song Y , et al. Radiofrequency ablation or microwave ablation combined with transcatheter arterial chemoembolization in treatment of hepatocellular carcinoma by comparing with radiofrequency ablation alone. Chin J Cancer Res 2014; 26(1): 112-8.

Facciorusso A , Di Maso M , Muscatiello N . Microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma: a systematic review and meta—analysis. Int J Hyperthermia 2016; 32(3): 339-44.

Simon CJ , Dupuy DE , Mayo—Smith WW . Microwave ablation: principles and applications. Radiographics 2005; 25(Suppl 1): S69—83.

Lubner MG , Brace CL , Hinshaw JL , Lee Jr FT . Microwave tumor ablation: mechanism of action, clinical results, and devices. J Vasc Interv Radiol 2010; 21(8 Suppl): S192-203.

Vogl TJ , Nour—Eldin NA , Hammerstingl RM , Panahi B , Naguib NNN . Microwave ablation (MWA): basics, technique and results in primary and metastatic liver neoplasms—review article. Rofo 2017; 189(11): 1055-66.

Sidoff L , Dupuy DE . Clinical experiences with microwave thermal ablation of lung malignancies. Int J Hyperthermia 2017; 33(1): 25-33.

Yu Q , Liu C , Navuluri R , Ahmed O . Percutaneous microwave ablation versus radiofrequency ablation of hepatocellular carcinoma: a meta—analysis of randomized controlled trials. Abdom Radiol 2021; 46(9): 4467—75.

Iezzi R , Cioni R , Basile D , Tosoratti N , Posa A , Busso M , et al. Standardizing percutaneous microwave ablation in the treatment of lung tumors: a prospective multicenter trial (MALT study). Eur Radiol 2021; 31(4): 2173-82.

Nault JC , Sutter O , Nahon P , Ganne—Carrié N , Séror O . Percutaneous treatment of hepatocellular carcinoma: state of the art and innovations. J Hepatol 2018; 68(4): 783—97.

Kurilova I , Gonzalez—Aguirre A , Beets—Tan RG , Erinjeri J , Petre EN , Gonen M , et al. Microwave ablation in the management of colorectal cancer pulmonary metastases. Cardiovasc Intervent Radiol 2018; 41(10): 1530-44.

Amoils SP . The Joule Thomson cryoprobe. Arch Ophthalmol 1967; 78(2): 201-7.

Thurlow PC , Azhideh A , Ho CK , Stratchko LM , Pooyan A , Alipour E , et al. Thermal protection techniques for image—guided musculoskeletal ablation. Radiographics 2025; 45(4): e240078.

Georgiades CS , Hong K , Bizzell C , Geschwind JF , Rodriguez R . Safety and efficacy of CT—guided percutaneous cryoablation for renal cell carcinoma. J Vasc Interv Radiol 2008; 19(9): 1302-10.

Orkut S , De Marini P , Tan ASM , Garnon J , Koch G , Tricard T , et al. Profile and methodology of ancillary protective measures employed during percutaneous renal cryoablation in a single high—volume centre. Radiol Med 2025; 130(4): 493-507.

Zondervan PJ , Buijs M , de la Rosette JJ , van Delden O , van Lienden K , Laguna MP . Cryoablation of small kidney tumors. Int J Surg 2016; 36(Pt C): 533-40.

Zargar H , Atwell TD , Cadeddu JA , de la Rosette JJ , Janetschek G , Kaouk JH , et al. Cryoablation for small renal masses: selection criteria, complications, and functional and oncologic results. Eur Urol 2016; 69(1): 116-28.

Dupuy DE , Hong R , Oliver B , Goldberg SN . Radiofrequency ablation of spinal tumors: temperature distribution in the spinal canal. AJR Am J Roentgenol 2000; 175(5): 1263-6.

Callstrom MR , Charboneau JW . Image—guided palliation of painful metastases using percutaneous ablation. Tech Vasc Interv Radiol 2007; 10(2): 120-31.

Swarm RA , Paice JA , Anghelescu DL , Are M , Bruce JY , Buga S , et al. the BCPS. Adult cancer pain, version 3.2019, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 2019; 17(8): 977-1007.

Ahmed M , Solbiati L , Brace CL , Breen DJ , Callstrom MR , Charboneau JW , et al. the International Working Group on Image—guided Tumor Ablation, the Interventional Oncology Sans Frontières Expert Panel, the Technology Assessment Committee of the Society of Interventional Radiology, Standard of Practice Committee of the Cardiovascular and Interventional Radiological Society of Europe. Image—guided tumor ablation: standardization of terminology and reporting criteria—a 10—year update. Radiology 2014; 273(1): 241—60.

Chu KF , Dupuy DE . Thermal ablation of tumours: biological mechanisms and advances in therapy. Nat Rev Cancer 2014; 14(3): 199-208.

Sloan AE , Ahluwalia MS , Valerio—Pascua J , Manjila S , Torchia MG , Jones SE , et al. Results of the NeuroBlate system first—in—humans phase I clinical trial for recurrent glioblastoma: clinical article. J Neurosurg 2013; 118(6): 1202-19.

Rahmathulla G , Recinos PF , Kamian K , Mohammadi AM , Ahluwalia MS , Barnett GH . MRI—guided laser interstitial thermal therapy in neuro—oncology: a review of its current clinical applications. Oncology 2014; 87(2): 67-82.

Scheffer HJ , Nielsen K , de Jong MC , van Tilborg AA , Vieveen JM , Bouwman AR , et al. Irreversible electroporation for nonthermal tumor ablation in the clinical setting: a systematic review of safety and efficacy. J Vasc Interv Radiol 2014; 25(7): 997-1011. quiz 1011.

Xia ZY, Xiang JC, Xu JZ, Sun JX, Wang S, Xia QD. Irreversible electroporation synergizes with oncolytic virus enhances the infiltration of cytotoxic T lymphocytes in the tumor immune microenvironment: a leap from focal therapy to immunotherapy for prostate cancer. J Immunother Cancer 2025; 13(4): e009794.

Kowalczyk KJ , Choueiri TK , Hevelone ND , Trinh QD , Lipsitz SR , Nguyen PL , et al. Comparative effectiveness, costs and trends in treatment of small renal masses from 2005 to 2007. BJU Int 2013; 112(4): E273—80.

Goldberg SN , Gazelle GS , Mueller PR . Thermal ablation therapy for focal malignancy: a unified approach to underlying principles, techniques, and diagnostic imaging guidance. AJR Am J Roentgenol 2000; 174(2): 323-31.

Brace CL . Radiofrequency and microwave ablation of the liver, lung, kidney, and bone: what are the differences? Curr Probl Diagn Radiol 2009; 38(3): 135-43.

Vogl TJ , Farshid P , Naguib NN , Zangos S . Thermal ablation therapies in patients with breast cancer liver metastases: a review. Eur Radiol 2013; 23(3): 797-804.

Buy X , Tok CH , Szwarc D , Bierry G , Gangi A . Thermal protection during percutaneous thermal ablation procedures: interest of carbon dioxide dissection and temperature monitoring. Cardiovasc Intervent Radiol 2009; 32(3): 529-34.

Diehn FE , Neeman Z , Hvizda JL , Wood BJ . Remote thermometry to avoid complications in radiofrequency ablation. J Vasc Interv Radiol 2003; 14(12): 1569-76.

Ahmed M , Liu Z , Afzal KS , Weeks D , Lobo SM , Kruskal JB , et al. Radiofrequency ablation: effect of surrounding tissue composition on coagulation necrosis in a canine tumor model. Radiology 2004; 230(3): 761-7.

Goldberg SN , Gazelle GS , Compton CC , Mueller PR , Tanabe KK . Treatment of intrahepatic malignancy with radiofrequency ablation: radiologic—pathologic correlation. Cancer 2000; 88(11): 2452-63.

Moreira P , Tuncali K , Tempany CM , Tokuda J . The impact of placement errors on the tumor coverage in MRI—guided focal cryoablation of prostate cancer. Acad Radiol 2021; 28(6): 841-8.

Tokuda J , Wang Q , Tuncali K , Seethamraju RT , Tempany CM , Schmidt EJ . Temperature—sensitive frozen—tissue imaging for cryoablation monitoring using STIR—UTE MRI. Invest Radiol 2020; 55(5): 310-7.

Georgiades C , Rodriguez R , Azene E , Weiss C , Chaux A , Gonzalez—Roibon N , et al. Determination of the nonlethal margin inside the visible “ice—ball” during percutaneous cryoablation of renal tissue. Cardiovasc Intervent Radiol 2013; 36(3): 783—90.

Livraghi T, Meloni F, Di Stasi M, Rolle E, Solbiati L, Tinelli C, et al. Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: is resection still the treatment of choice? Hepatology 2008; 47(1): 82-9.

Yang X , Ye X , Zheng A , Huang G , Ni X , Wang J , et al. Percutaneous microwave ablation of stage I medically inoperable non—small cell lung cancer: clinical evaluation of 47 cases. J Surg Oncol 2014; 110(6): 758-63.

Wolf FJ , Grand DJ , Machan JT , Dipetrillo TA , Mayo—Smith WW , Dupuy DE . Microwave ablation of lung malignancies: effectiveness, CT findings, and safety in 50 patients. Radiology 2008; 247(3): 871-9.

Zheng K , Wang X . Techniques and status of hepatic arterial infusion chemotherapy for primary hepatobiliary cancers. Ther Adv Med Oncol 2024; 16: 17588359231225040.

Kim PN , Choi D , Rhim H , Rha SE , Hong HP , Lee J , et al. Planning ultrasound for percutaneous radiofrequency ablation to treat small ( ≤ 3 cm) hepatocellular carcinomas detected on computed tomography or magnetic resonance imaging: a multicenter prospective study to assess factors affecting ultrasound visibility. J Vasc Interv Radiol 2012; 23(5): 627-34.

Dodd 3rd GD , Frank MS , Aribandi M , Chopra S , Chintapalli KN . Radiofrequency thermal ablation: computer analysis of the size of the thermal injury created by overlapping ablations. AJR Am J Roentgenol 2001; 177(4): 777-82.

Davalos RV , Mir IL , Rubinsky B . Tissue ablation with irreversible electroporation. Ann Biomed Eng 2005; 33(2): 223-31.

Nolsøe CP , Torp—Pedersen S , Burcharth F , Horn T , Pedersen S , Christensen NE , et al. Interstitial hyperthermia of colorectal liver metastases with a US—guided Nd—YAG laser with a diffuser tip: a pilot clinical study. Radiology 1993; 187(2): 333-7.

Li X , Lovell JF , Yoon J , Chen X . Clinical development and potential of photothermal and photodynamic therapies for cancer. Nat Rev Clin Oncol 2020; 17(11): 657—74.

Shen L , Yang Z , Zhong Y , Bi Y , Yu J , Lu Q , et al. Cholesterol targeted catalytic hydrogel fueled by tumor debris can enhance microwave ablation therapy and anti—tumor immune response. Adv Sci 2025; 12(5): e2406975.

Zhu Y , Yang Z , Pan Z , Hao Y , Wang C , Dong Z , et al. Metallo—alginate hydrogel can potentiate microwave tumor ablation for synergistic cancer treatment. Sci Adv 2022; 8(31): eabo5285.

Ferrari M. Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer 2005; 5(3): 161—71.

Peer D , Karp JM , Hong S , Farokhzad OC , Margalit R , Langer R . Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 2007; 2(12): 751—60.

Shi J , Votruba AR , Farokhzad OC , Langer R . Nanotechnology in drug delivery and tissue engineering: from discovery to applications. Nano Lett 2010; 10(9): 3223-30.

Wu P , Han J , Gong Y , Liu C , Yu H , Xie N . Nanoparticle—based drug delivery systems targeting tumor microenvironment for cancer immunotherapy resistance: current advances and applications. Pharmaceutics 2022; 14(10): 1990.

Li Y , Li XM , Wei LS , Ye JF . Advancements in mitochondrial—targeted nanotherapeutics: overcoming biological obstacles and optimizing drug delivery. Front Immunol 2024; 15: 1451989.

Nishiyama N. Nanomedicine: nanocarriers shape up for long life. Nat Nanotechnol 2007; 2(4): 203-4.

Allen TM , Cullis PR . Liposomal drug delivery systems: from concept to clinical applications. Adv Drug Deliv Rev 2013; 65(1): 36-48.

Barenholz Y. Doxil®—the first FDA—approved nano—drug: lessons learned. J Control Release 2012; 160(2): 117-34.

Byrne JD , Betancourt T , Brannon—Peppas L . Active targeting schemes for nanoparticle systems in cancer therapeutics. Adv Drug Deliv Rev 2008; 60(15): 1615-26.

Tenchov R , Bird R , Curtze AE , Zhou Q . Lipid nanoparticles—from liposomes to mRNA vaccine delivery, a landscape of research diversity and advancement. ACS Nano 2021; 15(11): 16982-7015.

Paramshetti S , Angolkar M , Talath S , Osmani RAM , Spandana A , Al Fatease A , et al. Unravelling the in vivo dynamics of liposomes: insights into biodistribution and cellular membrane interactions. Life Sci 2024; 346: 122616.

Miele E , Spinelli GP , Miele E , Tomao F , Tomao S . Albumin—bound formulation of paclitaxel (Abraxane ABI—007) in the treatment of breast cancer. Int J Nanomedicine 2009; 4: 99-105.

Gelderblom H , Verweij J , Nooter K , Sparreboom A . Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation. Eur J Cancer 2001; 37(13): 1590-8.

Yin H , Kanasty RL , Eltoukhy AA , Vegas AJ , Dorkin JR , Anderson DG . Non—viral vectors for gene—based therapy. Nat Rev Genet 2014; 15(8): 541—55.

Sercombe L , Veerati T , Moheimani F , Wu SY , Sood AK , Hua S . Advances and challenges of liposome assisted drug delivery. Front Pharmacol 2015; 6: 286.

Wang J , Tan M , Wang Y , Liu X , Lin A . Advances in modification and delivery of nucleic acid drugs. J Zhejiang Univ, Med Sci 2023; 52(4): 417-28. Chinese.

Felgner PL , Gadek TR , Holm M , Roman R , Chan HW , Wenz M , et al. Lipofection: a highly efficient, lipid—mediated DNA—transfection procedure. Proc Natl Acad Sci USA 1987; 84(21): 7413-7.

Akinc A , Maier MA , Manoharan M , Fitzgerald K , Jayaraman M , Barros S , et al. The Onpattro story and the clinical translation of nanomedicines containing nucleic acid—based drugs. Nat Nanotechnol 2019; 14(12): 1084-7.

Lin KP , Yang CC , Lee YC , Lee MJ , Vest J , Sweetser MT , et al. Patisiran, an RNAi therapeutic for hereditary transthyretin—mediated amyloidosis: sub—analysis in Taiwanese patients from the APOLLO study. J Formos Med Assoc 2024; 123(9): 975-84.

Hanahan D , Coussens LM . Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell 2012; 21(3): 309—22.

de Visser KE , Joyce JA . The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth. Cancer Cell 2023; 41(3): 374-403.

Arnol D , Schapiro D , Bodenmiller B , Saez—Rodriguez J , Stegle O . Modeling cell—cell interactions from spatial molecular data with spatial variance component analysis. Cell Rep 2019; 29(1): 202-211.e6.

Bejarano L , Jorda¯o MJC , Joyce JA . Therapeutic targeting of the tumor microenvironment. Cancer Discov 2021; 11(4): 933-59.

Han D , Xu Z , Zhuang Y , Ye Z , Qian Q . Current progress in CAR—T cell therapy for hematological malignancies. J Cancer 2021; 12(2): 326-34.

Binnewies M , Roberts EW , Kersten K , Chan V , Fearon DF , Merad M , et al. Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat Med 2018; 24(5): 541—50.

Spranger S , Gajewski TF . Impact of oncogenic pathways on evasion of antitumour immune responses. Nat Rev Cancer 2018; 18(3): 139-47.

He M , Roussak K , Ma F , Borcherding N , Garin V , White M , et al. CD5 expression by dendritic cells directs T cell immunity and sustains immunotherapy responses. Science 2023; 379(6633): eabg2752.

Hu J , Arvejeh PM , Bone S , Hett E , Marincola FM , Roh KH . Nanocarriers for cutting—edge cancer immunotherapies. J Transl Med 2025; 23(1): 447.

Sahu K , Satapathy T , Sahu P , Chandrakar O . Nanocarrier—induced inflammation: mechanisms, immunometabolic impacts and strategies for safer design. TransMed 2026; 1(1): 100002.

Overchuk M , Zheng G . Overcoming obstacles in the tumor microenvironment: recent advancements in nanoparticle delivery for cancer theranostics. Biomaterials 2018; 156: 217-37.

Yang M , Li J , Gu P , Fan X . The application of nanoparticles in cancer immunotherapy: targeting tumor microenvironment. Bioact Mater 2020; 6(7): 1973-87.

Blanco E , Shen H , Ferrari M . Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nat Biotechnol 2015; 33(9): 941-51.

Prabhakar U , Maeda H , Jain RK , Sevick—Muraca EM , Zamboni W , Farokhzad OC , et al. Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology. Cancer Res 2013; 73(8): 2412-7.

Yu Z , Wang D , Qi Y , Liu J , Zhou T , Rao W , et al. Autologous—cancer—cryoablation—mediated nanovaccine augments systematic immunotherapy. Mater Horiz 2023; 10(5): 1661-77.

Liu Y , Qiao L , Zhang S , Wan G , Chen B , Zhou P , et al. Dual pH—responsive multifunctional nanoparticles for targeted treatment of breast cancer by combining immunotherapy and chemotherapy. Acta Biomater 2018; 66: 310-24.

Luo L , Iqbal MZ , Liu C , Xing J , Akakuru OU , Fang Q , et al. Engineered nano—immunopotentiators efficiently promote cancer immunotherapy for inhibiting and preventing lung metastasis of melanoma. Biomaterials 2019; 223: 119464.

Gajewski TF , Schreiber H , Fu YX . Innate and adaptive immune cells in the tumor microenvironment. Nat Immunol 2013; 14(10): 1014-22.

Quail DF , Joyce JA . Microenvironmental regulation of tumor progression and metastasis. Nat Med 2013; 19(11): 1423-37.

Huang M , Yang X , Li C , Chen H , Pan Y , Chen L , et al. Sepsis—induced PICS: immunometabolic mechanisms, emerging biomarkers, and precision management. TransMed 2026; 1(1): 100009.

Han S , Wang W , Wang S , Yang T , Zhang G , Wang D , et al. Tumor microenvironment remodeling and tumor therapy based on M2—like tumor associated macrophage—targeting nano—complexes. Theranostics 2021; 11(6): 2892—916.

Han S , Chi Y , Yang Z , Ma J , Wang L . Tumor microenvironment regulation and cancer targeting therapy based on nanoparticles. J Funct Biomater 2023; 14(3): 136.

Mantovani A , Marchesi F , Malesci A , Laghi L , Allavena P . Tumour—associated macrophages as treatment targets in oncology. Nat Rev Clin Oncol 2017; 14(7): 399-416.

De Palma M , Lewis CE . Macrophage regulation of tumor responses to anticancer therapies. Cancer Cell 2013; 23(3): 277-86.

Sica A , Larghi P , Mancino A , Rubino L , Porta C , Totaro MG , et al. Macrophage polarization in tumour progression. Semin Cancer Biol 2008; 18(5): 349-55.

Ge W , Wu W . Influencing factors and significance of tumor—associated macrophage polarization in tumor microenvironment. Chin J Lung Cancer 2023; 26(3): 228-37. Chinese.

Boutilier AJ , Elsawa SF . Macrophage polarization states in the tumor microenvironment. Int J Mol Sci 2021; 22(13): 6995.

Zanganeh S , Hutter G , Spitler R , Lenkov O , Mahmoudi M , Shaw A , et al. Iron oxide nanoparticles inhibit tumour growth by inducing pro—inflammatory macrophage polarization in tumour tissues. Nat Nanotechnol 2016; 11(11): 986—94.

Wang M , Pan W , Xu Y , Zhang J , Wan J , Jiang H . Microglia—mediated neuroinflammation: a potential target for the treatment of cardiovascular diseases. J Inflamm Res 2022; 15: 3083-94.

Ling Y , Liang X , Yan K , Zeng G , Zhu X , Jiang J , et al. Bimetallic Ca/Zn nanoagonist remould the immunosuppressive hepatocellular carcinoma microenvironment following incomplete microwave ablation via pyroptosis and the sting signaling pathway. Adv Sci 2025; 12(23): e2500670.

Constantino J , Gomes C , Falcão A , Neves BM , Cruz MT . Dendritic cell—based immunotherapy: a basic review and recent advances. Immunol Res 2017; 65(4): 798-810.

Maier B, Leader AM, Chen ST, Tung N, Chang C, LeBerichel J, et al. A conserved dendritic—cell regulatory program limits antitumour immunity. Nature 2020; 580(7802): 257—62.

Gardner A , Ruffell B . Dendritic cells and cancer immunity. Trends Immunol 2016; 37(12): 855-65.

Luri—Rey C , Teijeira Á , Wculek SK , de Andrea C , Herrero C , Lopez—Janeiro A , et al. Cross—priming in cancer immunology and immunotherapy. Nat Rev Cancer 2025; 25(4): 249—73.

Liu Q , Zhu H , Liu Y , Musetti S , Huang L . BRAF peptide vaccine facilitates therapy of murine BRAF—mutant melanoma. Cancer Immunol Immunother 2018; 67(2): 299-310.

Li X , Liu Y , Ke J , Wang Z , Han M , Wang N , et al. Enhancing radiofrequency ablation for hepatocellular carcinoma: nano—epidrug effects on immune modulation and antigenicity restoration. Adv Mater 2024; 36(52): e2414365.

Tang B , Zhang X , Sun Y , Luo J , Weng Q , Zhang C , et al. Tumor—targeted FABP5/STING cascade promote radiofrequency ablation induced ferroptosis and intratumoral immune rewiring in hepatocellular carcinoma. Adv Sci 2025; 12(45): e07864.

Liu YN , Yang JF , Huang DJ , Ni HH , Zhang CX , Zhang L , et al. Hypoxia induces mitochondrial defect that promotes T cell exhaustion in tumor microenvironment through MYC—regulated pathways. Front Immunol 2020; 11: 1906.

Wherry EJ . T cell exhaustion. Nat Immunol 2011; 12(6): 492-9.

Chiu DK , Tse AP , Xu IM , Di Cui J , Lai RK , Li LL , et al. Hypoxia inducible factor HIF—1 promotes myeloid—derived suppressor cells accumulation through ENTPD2/CD39L1 in hepatocellular carcinoma. Nat Commun 2017; 8(1): 517.

Huang L , Zhu J , Xiong W , Feng J , Yang J , Lu X , et al. Tumor—generated reactive oxygen species storm for high—performance ferroptosis therapy. ACS Nano 2023; 17(12): 11492-506.

Ochoa de Olza M , Navarro Rodrigo B , Zimmermann S , Coukos G . Turning up the heat on non—immunoreactive tumours: opportunities for clinical development. Lancet Oncol 2020; 21(9): e419-30.

Chaturvedi P , Gilkes DM , Takano N , Semenza GL . Hypoxia—inducible factor—dependent signaling between triple—negative breast cancer cells and mesenchymal stem cells promotes macrophage recruitment. Proc Natl Acad Sci USA 2014; 111(20): E2120—9.

Noman MZ , Desantis G , Janji B , Hasmim M , Karray S , Dessen P , et al. PD—L1 is a novel direct target of HIF—1a, and its blockade under hypoxia enhanced MDSC—mediated T cell activation. J Exp Med 2014; 211(5): 781-90.

Song J , Wang H , Meng X , Li W , Qi J . A hypoxia—activated and microenvironment—remodeling nanoplatform for multifunctional imaging and potentiated immunotherapy of cancer. Nat Commun 2024; 15(1): 10395.

Zhou T , Liang X , Wang P , Hu Y , Qi Y , Jin Y , et al. A hepatocellular carcinoma targeting nanostrategy with hypoxia—ameliorating and photothermal abilities that, combined with immunotherapy, inhibits metastasis and recurrence. ACS Nano 2020; 14(10): 12679-96.

Zhang Y , Li B , He J , Meng Y , Zhan M , Lu C , et al. Hemoglobin—loaded hollow mesoporous carbon—gold nanocomposites enhance microwave ablation through hypoxia relief. J Nanobiotechnology 2025; 23(1): 326.

Dharmaratne NU , Kaplan AR , Glazer PM . Targeting the hypoxic and acidic tumor microenvironment with pH—sensitive peptides. Cells 2021; 10(3): 541.

Adochite RC , Moshnikova A , Carlin SD , Guerrieri RA , Andreev OA , Lewis JS , et al. Targeting breast tumors with pH (low) insertion peptides. Mol Pharm 2014; 11(8): 2896—905.

Demoin DW , Wyatt LC , Edwards KJ , Abdel—Atti D , Sarparanta M , Pourat J , et al. PET imaging of extracellular pH in tumors with 64Cu— and 18F—Labeled pHLIP peptides: a structure—activity optimization study. Bioconjug Chem 2016; 27(9): 2014-23.

Bergsbaken T , Fink SL , Cookson BT . Pyroptosis: host cell death and inflammation. Nat Rev Microbiol 2009; 7(2): 99-109.

Min R , Bai Y , Wang NR , Liu X . Gasdermins in pyroptosis, inflammation, and cancer. Trends Mol Med 2025; 31(9): 860-75.

He WT , Wan H , Hu L , Chen P , Wang X , Huang Z , et al. Gasdermin D is an executor of pyroptosis and required for interleukin—1b secretion. Cell Res 2015; 25(12): 1285-98.

Shi J , Zhao Y , Wang K , Shi X , Wang Y , Huang H , et al. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature 2015; 526(7575): 660-5.

Kayagaki N , Stowe IB , Lee BL , O’Rourke K , Anderson K , Warming S , et al. Caspase—11 cleaves gasdermin D for non—canonical inflammasome signalling. Nature 2015; 526(7575): 666-71.

Wang Y , Gao W , Shi X , Ding J , Liu W , He H , et al. Chemotherapy drugs induce pyroptosis through caspase—3 cleavage of a gasdermin. Nature 2017; 547(7661): 99-103.

Yu Q , Sun S , Yang N , Pei Z , Chen Y , Nie J , et al. Self—cascaded pyroptosis—STING initiators for catalytic metalloimmunotherapy. J Am Chem Soc 2025; 147(4): 3161-73.

Zhang Y , Jia Q , Li J , Wang J , Liang K , Xue X , et al. Copper—bacteriochlorin nanosheet as a specific pyroptosis inducer for robust tumor immunotherapy. Adv Mater 2023; 35(44): e2305073.

Xiao H , Li X , Liang S , Yang S , Han S , Huang J , et al. Dual—responsive nanomedicine activates programmed antitumor immunity through targeting lymphatic system. ACS Nano 2024; 18(17): 11070-83.

Chen B , Yan Y , Yang Y , Cao G , Wang X , Wang Y , et al. A pyroptosis nanotuner for cancer therapy. Nat Nanotechnol 2022; 17(7): 788—98.

Zhang Z , Zhang Y , Xia S , Kong Q , Li S , Liu X , et al. Gasdermin E suppresses tumour growth by activating anti—tumour immunity. Nature 2020; 579(7799): 415-20.

Wang Q , Wang Y , Ding J , Wang C , Zhou X , Gao W , et al. A bioorthogonal system reveals antitumour immune function of pyroptosis. Nature 2020; 579(7799): 421-6.

Zhang J , Hu Y , Wen X , Yang Z , Wang Z , Feng Z , et al. Tandem—controlled lysosomal assembly of nanofibres induces pyroptosis for cancer immunotherapy. Nat Nanotechnol 2025; 20(4): 563-74.

Wang T , Wu Q , Zhu C , Zhang Z , Gu Y , Chang Z , et al. Protein corona—detachable microwave ablation amplifiers actuate pyroptosis to repolarize immortal cancer into senescent ones. ACS Nano 2025; 19(32): 29577-92.

Yagoda N , von Rechenberg M , Zaganjor E , Bauer AJ , Yang WS , Fridman DJ , et al. RAS—RAF—MEK—dependent oxidative cell death involving voltage—dependent anion channels. Nature 2007; 447(7146): 864-8.

Liu X , Kim CN , Yang J , Jemmerson R , Wang X . Induction of apoptotic program in cell—free extracts: requirement for dATP and cytochrome C. Cell 1996; 86(1): 147—57.

Kerr JF , Wyllie AH , Currie AR . Apoptosis: a basic biological phenomenon with wide—ranging implications in tissue kinetics. Br J Cancer 1972; 26(4): 239-57.

Dixon SJ , Lemberg KM , Lamprecht MR , Skouta R , Zaitsev EM , Gleason CE , et al. Ferroptosis: an iron—dependent form of nonapoptotic cell death. Cell 2012; 149(5): 1060-72.

Yang WS , SriRamaratnam R , Welsch ME , Shimada K , Skouta R , Viswanathan VS , et al. Regulation of ferroptotic cancer cell death by GPX4. Cell 2014; 156(1—2): 317-31.

Doll S , Proneth B , Tyurina YY , Panzilius E , Kobayashi S , Ingold I , et al. ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. Nat Chem Biol 2017; 13(1): 91-8.

Yang WS , Stockwell BR . Synthetic lethal screening identifies compounds activating iron—dependent, nonapoptotic cell death in oncogenic—RAS—harboring cancer cells. Chem Biol 2008; 15(3): 234—45.

Gaschler MM , Hu F , Feng H , Linkermann A , Min W , Stockwell BR . Determination of the subcellular localization and mechanism of action of ferrostatins in suppressing ferroptosis. ACS Chem Biol 2018; 13(4): 1013-20.

Jiang X , Stockwell BR , Conrad M . Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol 2021; 22(4): 266—82.

Zhang S , Wu X , Liao X , Zhang S . Nanodrug hijacking blood transferrin for ferroptosis—mediated cancer treatment. J Am Chem Soc 2024; 146(12): 8567-75.

Zhu L , You Y , Zhu M , Song Y , Zhang J , Hu J , et al. Ferritin—hijacking nanoparticles spatiotemporally directing endogenous ferroptosis for synergistic anticancer therapy. Adv Mater 2022; 34(51): e2207174.

Feng Y , Chen Q , Jin C , Ruan Y , Chen Q , Lin W , et al. Microwave—activated Cu—doped zirconium metal—organic framework for a highly effective combination of microwave dynamic and thermal therapy. J Control Release 2023; 361: 102—14.

Liu T , Liu W , Zhang M , Yu W , Gao F , Li C , et al. Ferrous—supply—regeneration nanoengineering for cancer—cell—specific ferroptosis in combination with imaging—guided photodynamic therapy. ACS Nano 2018; 12(12): 12181-92.

Fu F , Wang W , Wu L , Wang W , Huang Z , Huang Y , et al. Inhalable biomineralized liposomes for cyclic Ca2+—burst—centered endoplasmic reticulum stress enhanced lung cancer ferroptosis therapy. ACS Nano 2023; 17(6): 5486-502.

Hou W , Hong W , Cai S , Guo D , Yan Z , Zhu J , et al. RRM2—targeted nanocarrier enhances radiofrequency ablation efficacy in hepatocellular carcinoma through ferroptosis amplification and immune remodeling. iMeta 2025; 4(5): e70067.

Zhang X , Zhang Y , Lv X , Zhang P , Xiao C , Chen X . DNA—free guanosine—based polymer nanoreactors with multienzyme activities for ferroptosis—apoptosis combined antitumor therapy. ACS Nano 2024; 18(49): 33531-44.

Zerbini A , Pilli M , Laccabue D , Pelosi G , Molinari A , Negri E , et al. Radiofrequency thermal ablation for hepatocellular carcinoma stimulates autologous NK—cell response. Gastroenterology 2010; 138(5): 1931-42.

Krysko DV , Garg AD , Kaczmarek A , Krysko O , Agostinis P , Vandenabeele P . Immunogenic cell death and DAMPs in cancer therapy. Nat Rev Cancer 2012; 12(12): 860-75.

Crosby D , Bhatia S , Brindle KM , Coussens LM , Dive C , Emberton M , et al. Early detection of cancer. Science 2022; 375(6586): eaay9040.

Wahida A , Buschhorn L , Fröhling S , Jost PJ , Schneeweiss A , Lichter P , et al. The coming decade in precision oncology: six riddles. Nat Rev Cancer 2023; 23(1): 43-54.

Chen R , Mias GI , Li—Pook—Than J , Jiang L , Lam HY , Chen R , et al. Personal omics profiling reveals dynamic molecular and medical phenotypes. Cell 2012; 148(6): 1293-307.

Kim SY , An J , Lim YS , Han S , Lee JY , Byun JH , et al. MRI with liver—specific contrast for surveillance of patients with cirrhosis at high risk of hepatocellular carcinoma. JAMA Oncol 2017; 3(4): 456-63.

James ML, Gambhir SS. A molecular imaging primer: modalities, imaging agents, and applications. Physiol Rev 2012; 92(2): 897-965.

Abd Elkodous M , El—Sayyad GS , Abdelrahman IY , El—Bastawisy HS , Mohamed AE , Mosallam FM , et al. Therapeutic and diagnostic potential of nanomaterials for enhanced biomedical applications. Colloids Surf B Biointerfaces 2019; 180: 411-28.

Dykman L , Khlebtsov N . Gold nanoparticles in biomedical applications: recent advances and perspectives. Chem Soc Rev 2012; 41(6): 2256—82.

Chen Y , Xianyu Y , Jiang X . Surface modification of gold nanoparticles with small molecules for biochemical analysis. Acc Chem Res 2017; 50(2): 310-9.

Keliher EJ , Yoo J , Nahrendorf M , Lewis JS , Marinelli B , Newton A , et al. 89Zr—labeled dextran nanoparticles allow in vivo macrophage imaging. Bioconjug Chem 2011; 22(12): 2383—9.

Wu Q , Tan L , Ren X , Fu C , Chen Z , Ren J , et al. Metal—organic framework—based nano—activators facilitating microwave combined therapy via a divide—and—conquer tactic for triple—negative breast cancer. ACS Nano 2023; 17(24): 25575-90.

Zhang S , Xie F , Li K , Zhang H , Yin Y , Yu Y , et al. Gold nanoparticle—directed autophagy intervention for antitumor immunotherapy via inhibiting tumor—associated macrophage M2 polarization. Acta Pharm Sin B 2022; 12(7): 3124-38.

Li S , Xu F , Ren X , Tan L , Fu C , Wu Q , et al. H ₂S—reactivating antitumor immune response after microwave thermal therapy for long—term tumor suppression. ACS Nano 2023; 17(19): 19242-53.

Zeng X , Liao G , Li S , Liu H , Zhao X , Li S , et al. Eliminating METTL1—mediated accumulation of PMN—MDSCs prevents hepatocellular carcinoma recurrence after radiofrequency ablation. Hepatology 2023; 77(4): 1122-38.

Nijkamp MW , van der Bilt JD , de Bruijn MT , Molenaar IQ , Voest EE , van Diest PJ , et al. Accelerated perinecrotic outgrowth of colorectal liver metastases following radiofrequency ablation is a hypoxia—driven phenomenon. Ann Surg 2009; 249(5): 814-23.

Shi L , Wang J , Ding N , Zhang Y , Zhu Y , Dong S , et al. Inflammation induced by incomplete radiofrequency ablation accelerates tumor progression and hinders PD—1 immunotherapy. Nat Commun 2019; 10(1): 5421.

Shi ZR , Duan YX , Cui F , Wu ZJ , Li MP , Song PP , et al. Integrated proteogenomic characterization reveals an imbalanced hepatocellular carcinoma microenvironment after incomplete radiofrequency ablation. J Exp Clin Cancer Res 2023; 42(1): 133.

Weiss MJ , Wolfgang CL . Irreversible electroporation: a novel pancreatic cancer therapy. Curr Probl Cancer 2013; 37(5): 262— 5.

Aymeric L , Apetoh L , Ghiringhelli F , Tesniere A , Martins I , Kroemer G , et al. Tumor cell death and ATP release prime dendritic cells and efficient anticancer immunity. Cancer Res 2010; 70(3): 855-8.

Wu S , Xu W , Shan X , Sun L , Liu S , Sun X , et al. Targeting splenic myeloid cells with nanobiologics to prevent postablative pancreatic cancer recurrence via inducing antitumor peripheral trained immunity. Adv Sci 2025; 12(21): e2413562.

Deng X , Shao Z , Zhao Y . Solutions to the drawbacks of photothermal and photodynamic cancer therapy. Adv Sci 2021; 8(3): 2002504.

Hagiwara S , Nishida N , Kudo M . Advances in immunotherapy for hepatocellular carcinoma. Cancers 2023; 15(7): 2070.

Izzo F , Thomas R , Delrio P , Rinaldo M , Vallone P , DeChiara A , et al. Radiofrequency ablation in patients with primary breast carcinoma: a pilot study in 26 patients. Cancer 2001; 92(8): 2036-44.

European Association for the Study of the Liver, the European Organisation for Research and Treatment of Cancer. EASL—EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 2012; 56(4): 908-43.

Ali MY , Grimm CF , Ritter M , Mohr L , Allgaier HP , Weth R , et al. Activation of dendritic cells by local ablation of hepatocellular carcinoma. J Hepatol 2005; 43(5): 817-22.

den Brok MH , Sutmuller RP , van der Voort R , Bennink EJ , Figdor CG , Ruers TJ , et al. In situ tumor ablation creates an antigen source for the generation of antitumor immunity. Cancer Res 2004; 64(11): 4024-9.

Shi L , Chen L , Wu C , Zhu Y , Xu B , Zheng X , et al. PD—1 blockade boosts radiofrequency ablation—elicited adaptive immune responses against tumor. Clin Cancer Res 2016; 22(5): 1173-84.

Zerbini A , Pilli M , Penna A , Pelosi G , Schianchi C , Molinari A , et al. Radiofrequency thermal ablation of hepatocellular carcinoma liver nodules can activate and enhance tumor—specific T—cell responses. Cancer Res 2006; 66(2): 1139-46.

Widenmeyer M , Shebzukhov Y , Haen SP , Schmidt D , Clasen S , Boss A , et al. Analysis of tumor antigen—specific T cells and antibodies in cancer patients treated with radiofrequency ablation. Int J Cancer 2011; 128(11): 2653-62.

Chen MS , Li JQ , Zheng Y , Guo RP , Liang HH , Zhang YQ , et al. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg 2006; 243(3): 321-38.

Mizukoshi E , Yamashita T , Arai K , Sunagozaka H , Ueda T , Arihara F , et al. Enhancement of tumor—associated antigen—specific T cell responses by radiofrequency ablation of hepatocellular carcinoma. Hepatology 2013; 57(4): 1448-57.

Liu Q , Zhang W , Jiao R , Lv Z , Lin X , Xiao Y , et al. Rational nanomedicine design enhances clinically physical treatment—inspired or combined immunotherapy. Adv Sci 2022; 9(29): e2203921.

Oroojalian F , Beygi M , Baradaran B , Mokhtarzadeh A , Shahbazi MA . Immune cell membrane—coated biomimetic nanoparticles for targeted cancer therapy. Small 2021; 17(12): e2006484.

Zhai Y , Wang J , Lang T , Kong Y , Rong R , Cai Y , et al. T lymphocyte membrane—decorated epigenetic nanoinducer of interferons for cancer immunotherapy. Nat Nanotechnol 2021; 16(11): 1271-80.

Guo H , Huang G , Long H , Wu W , Lin K , Qiao B , et al. Harnessing PD—1—overexpressing macrophage membrane for preparation of lenvatinib—loaded vesicles to boost immunotherapy against HCC recurrence after radiofrequency ablation. Biomaterials 2025; 323: 123433.

Takaki H , Imai N , Thomas CT , Yamakado K , Yarmohammadi H , Ziv E , et al. Changes in peripheral blood T—cell balance after percutaneous tumor ablation. Minim Invasive Ther Allied Technol 2017; 26(6): 331-7.

Yu M , Pan H , Che N , Li L , Wang C , Wang Y , et al. Microwave ablation of primary breast cancer inhibits metastatic progression in model mice via activation of natural killer cells. Cell Mol Immunol 2021; 18(9): 2153-64.

Leuchte K , Staib E , Thelen M , Gödel P , Lechner A , Zentis P , et al. Microwave ablation enhances tumor—specific immune response in patients with hepatocellular carcinoma. Cancer Immunol Immunother 2021; 70(4): 893-907.

Zhou W , Yu M , Pan H , Qiu W , Wang H , Qian M , et al. Microwave ablation induces Th1—type immune response with activation of ICOS pathway in early—stage breast cancer. J Immunother Cancer 2021; 9(4): e002343.

Kepp O, Marabelle A, Zitvogel L, Kroemer G. Oncolysis without viruses—inducing systemic anticancer immune responses with local therapies. Nat Rev Clin Oncol 2020; 17(1): 49-64.

Li L , Wang W , Pan H , Ma G , Shi X , Xie H , et al. Microwave ablation combined with OK—432 induces Th1—type response and specific antitumor immunity in a murine model of breast cancer. J Transl Med 2017; 15(1): 23.

Yin XY , Xie XY , Lu MD , Xu HX , Xu ZF , Kuang M , et al. Percutaneous thermal ablation of medium and large hepatocellular carcinoma: long—term outcome and prognostic factors. Cancer 2009; 115(9): 1914-23.

Qin S , Liu GJ , Huang M , Huang J , Luo Y , Wen Y , et al. The local efficacy and influencing factors of ultrasound—guided percutaneous microwave ablation in colorectal liver metastases: a review of a 4—year experience at a single center. Int J Hyperthermia 2019; 36(1): 36-43.

Xu F , Wei Z , Ye X . Immunomodulatory effects of microwave ablation on malignant tumors. Am J Cancer Res 2024; 14(6): 2714-30.

Zhu J , Yu M , Chen L , Kong P , Li L , Ma G , et al. Enhanced antitumor efficacy through microwave ablation in combination with immune checkpoints blockade in breast cancer: a pre—clinical study in a murine model. Diagn Interv Imaging 2018; 99(3): 135-42.

Rangamuwa K , Leong T , Weeden C , Asselin—Labat ML , Bozinovski S , Christie M , et al. Thermal ablation in non—small cell lung cancer: a review of treatment modalities and the evidence for combination with immune checkpoint inhibitors. Transl Lung Cancer Res 2021; 10(6): 2842-57.

Xing R , Gao J , Cui Q , Wang Q . Strategies to improve the antitumor effect of immunotherapy for hepatocellular carcinoma. Front Immunol 2021; 12: 783236.

Guo W , Chen Z , Wu Q , Tan L , Ren X , Fu C , et al. Prepared MW—immunosensitizers precisely release no to downregulate HIF—1a expression and enhance immunogenic cell death. Small 2024; 20(17): e2308055.

Ma X , Bi E , Lu Y , Su P , Huang C , Liu L , et al. Cholesterol induces CD8+ T cell exhaustion in the tumor microenvironment. Cell Metab 2019; 30(1): 143-156.e5.

Huang B , Song BL , Xu C . Cholesterol metabolism in cancer: mechanisms and therapeutic opportunities. Nat Metab 2020; 2(2): 132—41.

Liu X , Bao X , Hu M , Chang H , Jiao M , Cheng J , et al. Inhibition of PCSK9 potentiates immune checkpoint therapy for cancer. Nature 2020; 588(7839): 693—8.

Li X , Peng X , Zoulikha M , Boafo GF , Magar KT , Ju Y , et al. Multifunctional nanoparticle—mediated combining therapy for human diseases. Signal Transduct Target Ther 2024; 9(1): 1.

Krajczewski J , Rucin´ ska K , Townley HE , Kudelski A . Role of various nanoparticles in photodynamic therapy and detection methods of singlet oxygen. Photodiagnosis Photodyn Ther 2019; 26: 162-78.

Zhao X , Liu J , Fan J , Chao H , Peng X . Recent progress in photosensitizers for overcoming the challenges of photodynamic therapy: from molecular design to application. Chem Soc Rev 2021; 50(6): 4185—219.

Agostinis P , Berg K , Cengel KA , Foster TH , Girotti AW , Gollnick SO , et al. Photodynamic therapy of cancer: an update. CA Cancer J Clin 2011; 61(4): 250-81.

Snyder JW , Greco WR , Bellnier DA , Vaughan L , Henderson BW . Photodynamic therapy: a means to enhanced drug delivery to tumors. Cancer Res 2003; 63(23): 8126-31.

Ruan K , Song G , Ouyang G . Role of hypoxia in the hallmarks of human cancer. J Cell Biochem 2009; 107(6): 1053-62.

Su Q , Wang Z , Zhou H , Zhang M , Deng W , Wei X , et al. Eradication of large tumors by nanoscale drug self—assembly. Adv Mater 2024; 36(49): e2410536.

Lim CK , Shin J , Lee YD , Kim J , Oh KS , Yuk SH , et al. Phthalocyanine—aggregated polymeric nanoparticles as tumor—homing near—infrared absorbers for photothermal therapy of cancer. Theranostics 2012; 2(9): 871-9.

Jiang C , Davalos RV , Bischof JC . A review of basic to clinical studies of irreversible electroporation therapy. IEEE Trans Biomed Eng 2015; 62(1): 4-20.

Yarmush ML , Golberg A , Serša G , Kotnik T , Miklavcˇicˇ D . Electroporation—based technologies for medicine: principles, applications, and challenges. Annu Rev Biomed Eng 2014; 16(1): 295-320.

Onik G , Mikus P , Rubinsky B . Irreversible electroporation: implications for prostate ablation. Technol Cancer Res Treat 2007; 6(4): 295-300.

Krysko O , Løve Aaes T , Bachert C , Vandenabeele P , Krysko DV . Many faces of DAMPs in cancer therapy. Cell Death Dis 2013; 4(5): e631.

Kepp O , Tesniere A , Zitvogel L , Kroemer G . The immunogenicity of tumor cell death. Curr Opin Oncol 2009; 21(1): 71-6.

Kepp O , Tesniere A , Schlemmer F , Michaud M , Senovilla L , Zitvogel L , et al. Immunogenic cell death modalities and their impact on cancer treatment. Apoptosis 2009; 14(4): 364—75.

Tesniere A , Panaretakis T , Kepp O , Apetoh L , Ghiringhelli F , Zitvogel L , et al. Molecular characteristics of immunogenic cancer cell death. Cell Death Differ 2008; 15(1): 3-12.

Apetoh L , Ghiringhelli F , Tesniere A , Obeid M , Ortiz C , Criollo A , et al. Toll—like receptor 4—dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med 2007; 13(9): 1050-9.

Li X , Xu K , Li W , Qiu X , Ma B , Fan Q , et al. Immunologic response to tumor ablation with irreversible electroporation. PLoS One 2012; 7(11): e48749.

Neal RE , Rossmeisl Jr JH , Robertson JL , Arena CB , Davis EM , Singh RN , et al. Improved local and systemic anti—tumor efficacy for irreversible electroporation in immunocompetent versus immunodeficient mice. PLoS One 2013; 8(5): e64559.

Lewis SM , Williams A , Eisenbarth SC . Structure and function of the immune system in the spleen. Sci Immunol 2019; 4(33): eaau6085.

Cheng Q , Wei T , Farbiak L , Johnson LT , Dilliard SA , Siegwart DJ . Selective organ targeting (SORT) nanoparticles for tissue—specific mRNA delivery and CRISPR—Cas gene editing. Nat Nanotechnol 2020; 15(4): 313-20.

Mulder WJM , Ochando J , Joosten LAB , Fayad ZA , Netea MG . Therapeutic targeting of trained immunity. Nat Rev Drug Discov 2019; 18(7): 553-66.

Long X , Dai A , Huang T , Niu W , Liu L , Xu H , et al. Simultaneous delivery of dual inhibitors of DNA damage repair sensitizes pancreatic cancer response to irreversible electroporation. ACS Nano 2023; 17(13): 12915-32.

Luo B , Cheng T , Xiang Y , Sun S , Liu Y , Yan J , et al. Promoting retinal ganglion cell regeneration with targeted liposome—based delivery of MHY1485 for optic nerve repair. J Control Release 2025; 383: 113778.

Shi J , Kantoff PW , Wooster R , Farokhzad OC . Cancer nanomedicine: progress, challenges and opportunities. Nat Rev Cancer 2017; 17(1): 20-37.

Yuan D , He H , Wu Y , Fan J , Cao Y . Physiologically based pharmacokinetic modeling of nanoparticles. J Pharm Sci 2019; 108(1): 58-72.

Guo C , Lin L , Wang Y , Jing J , Gong Q , Luo K . Nano drug delivery systems for advanced immune checkpoint blockade therapy. Theranostics 2025; 15(11): 5440-80.

Adir O , Poley M , Chen G , Froim S , Krinsky N , Shklover J , et al. Integrating artificial intelligence and nanotechnology for precision cancer medicine. Adv Mater 2020; 32(13): e1901989.

Ho D , Wang P , Kee T . Artificial intelligence in nanomedicine. Nanoscale Horiz 2019; 4(2): 365-77.

Walkey CD , Olsen JB , Song F , Liu R , Guo H , Olsen DW , et al. Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles. ACS Nano 2014; 8(3): 2439-55.

Sammut SJ , Crispin—Ortuzar M , Chin SF , Provenzano E , Bardwell HA , Ma W , et al. Multi—omic machine learning predictor of breast cancer therapy response. Nature 2022; 601(7894): 623-9.

Chua IS , Gaziel—Yablowitz M , Korach ZT , Kehl KL , Levitan NA , Arriaga YE , et al. Artificial intelligence in oncology: path to implementation. Cancer Med 2021; 10(12): 4138-49.

Kratochvil MJ , Seymour AJ , Li TL , Pas¸ca SP , Kuo CJ , Heilshorn SC . Engineered materials for organoid systems. Nat Rev Mater 2019; 4(9): 606-22.

Veninga V , Voest EE . Tumor organoids: opportunities and challenges to guide precision medicine. Cancer Cell 2021; 39(9): 1190-201.

Wang Y , Ye Z , Lin Y , Zhao Y , Zhong D , Chen J , et al. The promise and potential of liver organoids: development, classification and application. TransMed 2026; 1(1): 100003.

Bai L , Reis RL , Chen S , Su J , Liu C . Organoid research: advanced models, precision medicine, and translational medicine. Organoid Res 2025; 1(1): 25060009.

Bakr E , Elshami FI , Okba EA , Mansour H , Shaban SY . Stimuli—responsive chitosan—coated ferrite nanocarriers for targeted capsaicin delivery and core—dependent HepG2—selective bioactivity. Sci Rep 2026; 16(1): 8957.

Torchilin VP . Multifunctional, stimuli—sensitive nanoparticulate systems for drug delivery. Nat Rev Drug Discov 2014; 13(11): 813-27.

Zhu L , Zhou Z , Mao H , Yang L . Magnetic nanoparticles for precision oncology: theranostic magnetic iron oxide nanoparticles for image—guided and targeted cancer therapy. Nanomedicine 2017; 12(1): 73-87.

Kwong GA , Ghosh S , Gamboa L , Patriotis C , Srivastava S , Bhatia SN . Synthetic biomarkers: a twenty—first century path to early cancer detection. Nat Rev Cancer 2021; 21(10): 655—68.

Luo Y , Yu Y , Chen Y , Li R , Zhang Y , Chen S . Liquid metal—based biomaterials and flexible devices for injectable and implantable healthcare. Acta Biomater 2025; 207: 1-33.

Gong Z , Zhou D , Wu D , Han Y , Yu H , Shen H , et al. Challenges and material innovations in drug delivery to central nervous system tumors. Biomaterials 2025; 319: 123180.

Khanna C , Hunter K . Modeling metastasis in vivo. Carcinogenesis 2005; 26(3): 513-23.

Paoloni M , Khanna C . Translation of new cancer treatments from pet dogs to humans. Nat Rev Cancer 2008; 8(2): 147—56.